DAIICHI SANKYO DEUTSCHLAND GmbH
- Pharmaceutical Sales 2011
-
Worldwide: 8.615 billion EURO
- Product Range
-
Cardiovascular diseases, metabolic disorders, thrombotic disorders, hypertension, bacterial infections
- Key Research Areas
-
Oncology, cardiovascular diseases, metabolic disorders, thrombotic disorders, hypertension, bacterial infections, hyperlipidemia
- R&D Expenditure 2011
-
Worldwide: 1.7 billion EURO (19.7 percent of Net Sales 2011)
- Employees in the Pharmaceuticals Division 2011
-
Worldwide: ca. 32,000
In Germany: ca. 1,200
(All data based on corporate information, as of: 05/2012)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page